Patent Drafting for Multiple Jurisdictions
Can Applicants File One Application and Obtain Adequate Protection in the U.S., Korea, EPO, and China?
A live 90-minute premium CLE video webinar with interactive Q&A
This CLE course will guide patent counsel on drafting for multiple jurisdictions. The panel will examine important considerations when drafting a single patent application, focusing on filing in the U.S., Korea, EPO, and China. The panel will discuss grace periods, data considerations, and how the choice of language when drafting can impact prosecution and beyond. The panel will offer best practices for drafting single patent applications for use in several countries.
Outline
- Grace period provisions
- Data considerations
- Language and terminology considerations
- Best practices
Benefits
The panel will review these and other key issues:
- Can I file a single patent application, or will a prior disclosure make this unfeasible?
- Do I file early with minimal data or wait until more data are available?
- What terminology should I use/avoid when drafting for multiple jurisdictions?
Faculty

K. Victoria Barker, Ph.D.
Attorney
Finnegan Henderson Farabow Garrett & Dunner
Dr. Barker is a Chartered UK and European patent attorney with experience in all areas of patent portfolio management... | Read More
Dr. Barker is a Chartered UK and European patent attorney with experience in all areas of patent portfolio management from drafting and filing applications to prosecution strategy and beyond to EPO opposition and appeal procedures. Her experience spans a broad range of chemical technologies and key jurisdictions including China, Japan, and Korea. Having worked on numerous global patent families Dr. Barker is well-practised in both developing and implementing a worldwide prosecution strategy that meets the requirements of local patent offices and the needs of clients.
Close
Thomas L. Irving
Partner
The Marbury Law Group
Mr. Irving has 47 years of experience in the field of IP law. His practice includes due diligence, patent prosecution,... | Read More
Mr. Irving has 47 years of experience in the field of IP law. His practice includes due diligence, patent prosecution, reissue and reexamination, patent interferences, and counseling, including prelitigation, Orange Book listings of patents covering FDA-approved drugs, and infringement and validity analysis in the chemical fields, as well as litigation. He has served as lead counsel in many patent interferences.
Close
Kyu Yun Kim
Associate
Finnegan Henderson Farabow Garrett & Dunner
Ms. Kim focuses on patent litigation and patent prosecution in the chemical and pharmaceutical fields. Her litigation... | Read More
Ms. Kim focuses on patent litigation and patent prosecution in the chemical and pharmaceutical fields. Her litigation experience includes conducting discovery on Abbreviated New Drug Application (ANDA) litigation. She has also researched various legal matters in preparation of inter partes review (IPR) proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office.
Close
Dr. Amanda K. Murphy, Ph.D.
Partner
Finnegan Henderson Farabow Garrett & Dunner
Dr. Murphy focuses her practice on client counseling and patent prosecution for a range of clients. She prepares new... | Read More
Dr. Murphy focuses her practice on client counseling and patent prosecution for a range of clients. She prepares new patent applications, prosecutes U.S. and foreign applications, and represents applicants at appeals and oral hearings before the PTAB. She has experience in prosecuting inter partes and ex partes reexamination applications, reissue applications, and patent term extension applications for approved pharmaceuticals, including obtaining supplemental protection certificates in Europe.
Close
Yieyie Yang, Ph.D.
Attorney
Finnegan Henderson Farabow Garrett & Dunner
Dr. Yang focuses on complex patent litigation before U.S. district courts and inter partes review (IPR) proceedings in... | Read More
Dr. Yang focuses on complex patent litigation before U.S. district courts and inter partes review (IPR) proceedings in the chemical, pharmaceutical, and biotechnological fields. She has experience representing pharmaceutical patent holders in Hatch-Waxman litigations and has drafted numerous appellant and appellee briefs for pharmaceutical clients at the U.S. Court of Appeals for the Federal Circuit. She has handled various aspects of trial preparation, including fact and expert discovery, depositions of key witnesses and experts, and motion practice, along with other pre-litigation due diligence and position analysis. She also has worked on multiple IPR cases on behalf of petitioners or patent owners and has been involved in all aspects of those cases. In addition, she has conducted a variety of due diligence analysis in the biotechnological field for licensing, acquisition, freedom-to-operate, and startup fundraising.
Close